Published in J Urol on January 01, 1997
Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int (2014) 1.40
Prostate cancer: 8. Urinary incontinence and erectile dysfunction. CMAJ (1999) 1.18
Detrusor underactivity is prevalent after radical prostatectomy: A urodynamic study including risk factors. Can Urol Assoc J (2013) 0.89
Post-radical prostatectomy incontinence: etiology and prevention. Rev Urol (2014) 0.82
Urinary continence following laparoscopic radical prostatectomy: Association with postoperative membranous urethral length measured using real-time intraoperative transrectal ultrasonography. Oncol Lett (2011) 0.78
Morphology and dynamics of the male pelvic floor before and after retrourethral transobturator sling placement: first insight using MRI. World J Urol (2012) 0.78
Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer. Rev Urol (2013) 0.78
Impact of posterior urethral plate repair on continence following robot-assisted laparoscopic radical prostatectomy. Yonsei Med J (2010) 0.77
The surgical procedure is the most important factor affecting continence recovery after laparoscopic radical prostatectomy. World J Mens Health (2013) 0.75
Posterior reconstruction and anterior suspension with single anastomotic suture in robot-assisted laparoscopic radical prostatectomy: a simple method to improve early return of continence. J Robot Surg (2009) 0.75
Urinary Incontinence Could Be Controlled by an Inflatable Penile Prosthesis. World J Mens Health (2016) 0.75
Impact of bladder dysfunction in the management of post radical prostatectomy stress urinary incontinence-a review. Transl Androl Urol (2017) 0.75
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol (2005) 1.39
[Penetration of methylmethacrylate-monomer in blood circulation following hip joint prosthesis surgery in man]. Chirurg (1974) 1.30
Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol (1991) 1.21
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. J Urol (1999) 1.14
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol (2001) 1.13
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl) (2010) 1.10
Stage migration in clinically localized prostate cancer. Eur Urol (2000) 1.04
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol (1999) 1.03
Urological findings in patients with neurosurgically treated tethered spinal cord. J Urol (1993) 0.99
[Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]. Urologe A (2003) 0.98
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml. Prostate (2001) 0.96
Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections. J Urol (1984) 0.96
[Influence of the bone-cement mixing time on hypotonic blood circulation reactions in hip-joint replacement surgery]. Chirurg (1975) 0.95
Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J Urol (1984) 0.95
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene (2006) 0.93
Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience. Cancer J Sci Am (1997) 0.93
The oxygen supply of the dog kidney: measurements of intrarenal pO 2 . Microvasc Res (1972) 0.92
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer. J Urol (2000) 0.92
Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol (1994) 0.92
The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma. Anticancer Res (2001) 0.91
Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population. Eur Urol (1985) 0.91
Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors. Eur Urol (1999) 0.89
Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer. Anticancer Res (2000) 0.89
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int (2003) 0.89
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene. Prostate (2011) 0.88
Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate (2001) 0.88
Improved net sodium transport of the isolated rat kidney. Z Gesamte Exp Med (1971) 0.87
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Eur Urol (2001) 0.87
Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients. Oncol Lett (2010) 0.85
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol (1998) 0.85
Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy. J Clin Oncol (1999) 0.85
Renal scarring after symptomatic and asymptomatic upper urinary tract infection: a prospective study. J Urol (1982) 0.85
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol (1998) 0.84
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. Folia Biol (Praha) (2003) 0.84
Autologous blood transfusion in radical prostatectomy: results in 263 patients. Eur Urol (1995) 0.84
[Perioperative and postoperative complications of pelvic lymphadenectomy and radical prostatectomy in 320 consecutive patients]. Urologe A (1995) 0.83
[Carcinoma in situ of the testis: clinical significance, diagnosis and therapy]. Urologe A (1989) 0.83
Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder: a comparative analysis for patients with bladder cancer. J Urol (2006) 0.83
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res (1989) 0.83
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology (1998) 0.82
Reversibility of preglomerular active vasoconstriction in the first weeks after complete unilateral ureteral obstruction by inhibition of prostaglandin synthesis. J Urol (1983) 0.82
[Early complications of radical prostatectomy. Pelvic vein compression caused by wound drainage]. Urologe A (1994) 0.82
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol (2008) 0.82
Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients. Eur Urol (1983) 0.82
Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors. Eur Urol (2001) 0.82
[Effect of dopamine on the intrarenal cAMP concentration]. Verh Dtsch Ges Inn Med (1975) 0.82
Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol (2001) 0.81
[Surgical results of epididymovasostomy and vaso-vasostomy]. Urologe A (1983) 0.81
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol (1992) 0.81
Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol (1984) 0.81
Pyelonephritic scarring in 213 patients with upper and lower urinary tract infections: long-term followup. J Urol (1984) 0.81
Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int (2003) 0.81
The correction of penile curvature with the Essed-Schröder technique: a long-term follow-up assessing functional aspects and quality of life. BJU Int (2000) 0.81
Rectourinary fistula repair using the Latzko technique. J Urol (1999) 0.81
Numerical chromosomal aberrations in transition-zone carcinomas of the prostate. J Urol (1997) 0.81
Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol (1987) 0.80
Pathophysiology of hydronephrotic atrophy: the cause and role of active preglomerular vasoconstriction. Urol Int (1983) 0.80
Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology. J Urol (2000) 0.80
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment. J Cancer Res Clin Oncol (1994) 0.80
[Ambulatory carboplatin monotherapy in advanced seminoma]. Urologe A (1990) 0.80
Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder. Oncol Res (1998) 0.80
High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol (2001) 0.80
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy. Prostate Cancer Prostatic Dis (2013) 0.80
Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence. BJU Int (2003) 0.80
Long-term results of the Stamey bladder neck suspension procedure: a patient questionnaire based outcome analysis. J Urol (1997) 0.80
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol (2001) 0.80
Immunohistochemical detection of p53 protein in human prostatic cancer. J Urol (1994) 0.79
[Functional results of various surgical techniques for radical prostatectomy]. Urologe A (2003) 0.79
Effect of angiotensin II antagonist, alpha-receptor blockage, and denervation on blood flow reduction in experimental, chronic hydronephrosis. Invest Urol (1980) 0.79
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2). Anticancer Res (1999) 0.79
[Vascular injuries during osteosynthesis in the proximal femoral shaft]. Zentralbl Chir (1974) 0.79
Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps. Anticancer Res (2001) 0.79
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy. Eur J Surg Oncol (2012) 0.79
Consecutive selective aspiration cytology of renal cortex and renal medulla in kidney transplants. Transplant Proc (1988) 0.79
[Etiology of Goodpasture's syndrome]. Med Klin (1973) 0.79
[Multilocular, giant angiomyolipoma of the kidney, adrenal gland and para-aortic lymph nodes. Case report of a 9-year-old boy with tuberous sclerosis]. Urologe A (1994) 0.79
Innovative treatment for clinically localized adenocarcinoma of the prostate: the future role of molecular imaging. Prostate (1999) 0.79
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol (1997) 0.79
Dyeing: a simple method for detecting positive or negative surgical margins. Urology (1995) 0.78
Endoscopic bladder neck suspension (Stamey-Pereyra) in female urinary stress incontinence. Long-term follow-up of 66 patients. Eur Urol (1984) 0.78
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. Urologe A (2001) 0.78
[Fast-track surgery in radical retropubic prostatectomy. First experiences with a comprehensive program to enhance postoperative convalescence]. Urologe A (2005) 0.78
Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy? Eur Urol (1997) 0.78
Do serum C-reactive protein measurements help to discriminate episodes of renal dysfunction in patients after renal transplantation? Clin Chim Acta (2001) 0.78
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer. J Urol (1998) 0.78
[Ureterorenoscopy (URS) in treatment of ureteral calculi. I. Safety and effectiveness of URS as auxiliary treatment after ESWL]. Urologe A (1999) 0.78
Influence of cause on choice of therapy in 174 patients with erectile dysfunction. J Urol (1992) 0.78
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone. Prostate Cancer Prostatic Dis (2002) 0.78
Modified surgical technique to correct congenital and acquired penile curvature. Eur Urol (1991) 0.78
[Molecular high throughput research in prostate carcinoma]. Urologe A (2007) 0.78
[Experiences with local collagen injection in male stress incontinence]. Urologe A (1997) 0.77
[Active surveillance for prostate cancer]. Urologe A (2008) 0.77
Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens. Urology (2001) 0.77
MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology. Radiol Res Pract (2010) 0.77
Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer. World J Urol (2001) 0.77
CO2-production by the isolated perfused rat kidney from 14C-labelled substrates. Res Exp Med (Berl) (1973) 0.77